Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Heparanase procoagulant activity is elevated in women using oral contraceptives.

Matan M, Axelman E, Brenner B, Nadir Y.

Hum Reprod. 2013 Sep;28(9):2372-80. doi: 10.1093/humrep/det257. Epub 2013 Jun 25.

PMID:
23800622
2.

An assay to evaluate heparanase procoagulant activity.

Nadir Y, Kenig Y, Drugan A, Shafat I, Brenner B.

Thromb Res. 2011 Oct;128(4):e3-8. doi: 10.1016/j.thromres.2011.03.008. Epub 2011 Apr 8.

PMID:
21481923
3.

Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.

Peled E, Rovitsky A, Axelman E, Norman D, Brenner B, Nadir Y.

Thromb Res. 2012 Jul;130(1):129-34. doi: 10.1016/j.thromres.2011.09.021. Epub 2011 Dec 10.

PMID:
22154361
4.

Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses.

Nadir Y, Saharov G, Hoffman R, Keren-Politansky A, Tzoran I, Brenner B, Shochat T.

Ann Hematol. 2015 Jul;94(7):1213-9. doi: 10.1007/s00277-015-2345-8. Epub 2015 Mar 7.

PMID:
25743687
5.

Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.

Nadir Y, Sarig G, Axelman E, Meir A, Wollner M, Shafat I, Hoffman R, Brenner B, Vlodavsky I, Haim N.

Thromb Res. 2014 Sep;134(3):639-42. doi: 10.1016/j.thromres.2014.07.006. Epub 2014 Jul 12.

PMID:
25065557
6.

[Cardiovascular risks of oral contraceptives: dose-response relationship].

Kelleher CC.

Contracept Fertil Sex (Paris). 1991 Apr;19(4):285-8. French.

PMID:
12343220
7.

Heparanase procoagulant activity.

Nadir Y, Brenner B.

Thromb Res. 2012 Apr;129 Suppl 1:S76-9. doi: 10.1016/S0049-3848(12)70021-X.

PMID:
22682139
8.
9.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
10.

Heparanase procoagulant activity in cancer progression.

Nadir Y, Brenner B.

Thromb Res. 2016 Apr;140 Suppl 1:S44-8. doi: 10.1016/S0049-3848(16)30097-4. Review.

PMID:
27067977
12.

Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.

Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.

Thromb Haemost. 1996 Nov;76(5):729-34.

PMID:
8950781
13.

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.

Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, B├╝ller HR, Rosing J.

Thromb Haemost. 2000 Jul;84(1):15-21.

PMID:
10928463
14.

Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives.

H├Âlschermann H, Terhalle HM, Zakel U, Maus U, Parviz B, Tillmanns H, Haberbosch W.

Thromb Haemost. 1999 Dec;82(6):1614-20.

PMID:
10613644
15.

Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.

Peled E, Melamed E, Portal TB, Axelman E, Norman D, Brenner B, Nadir Y.

Thromb Res. 2016 Mar;139:148-53. doi: 10.1016/j.thromres.2016.01.014. Epub 2016 Jan 24.

PMID:
26916313
16.

Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism.

Mercier I, Mader S, Calderone A.

Cardiovasc Res. 2003 Oct 1;59(4):883-92.

PMID:
14553828
17.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
18.

Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.

Zia A, Callaghan MU, Callaghan JH, Sawni A, Bartlett H, Backos A, Marshall S, Chitlur M, Rajpurkar M.

Am J Hematol. 2015 Aug;90(8):725-31. doi: 10.1002/ajh.24064.

19.

Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.

Fruzzetti F, Ricci C, Fioretti P.

Contraception. 1994 Jun;49(6):579-92.

PMID:
8070263
20.

Estrogen and progestin components of oral contraceptives: relationship to vascular disease.

Carr BR, Ory H.

Contraception. 1997 May;55(5):267-72. Review.

PMID:
9220222

Supplemental Content

Support Center